American Journal of Medical Genetics Part A, ISSN 1552-4825, 09/2013, Volume 161, Issue 9, pp. 2197 - 2203
ABSTRACT Angelman syndrome (AS) is a neurogenetic disorder caused by loss of expression of the maternal imprinted gene UBE3A on chromosome 15q11.2–q13....
15q11.2–q13 | Angelman syndrome | array CGH | copy number variation | deletion | breakpoints | birth incidence | Breakpoints | Birth incidence | Copy number variation | Array CGH | 15q11.2-q13 | Deletion | MOLECULAR CHARACTERIZATION | 15Q11-Q13 REARRANGEMENTS | PREVALENCE | IDENTIFICATION | FEATURES | CHILDREN | ARRAY-CGH | GENETICS & HEREDITY | EPILEPSY | PRADER-WILLI-SYNDROME | Chromosome Deletion | Chromosome Duplication | Angelman Syndrome - epidemiology | Humans | Angelman Syndrome - diagnosis | Child, Preschool | Male | Incidence | Chromosomes, Human, Pair 15 | Adolescent | Angelman Syndrome - genetics | Denmark - epidemiology | Female | Child | Medicine, Experimental | Medical research | Analysis | Mandible | Epilepsy | Uniparental disomy | Clonal deletion | Ataxia | Children | Mutation | Diagnosis | Health risk assessment | Chromosome 15 | Age | Ubiquitin-protein ligase | Genotypes
15q11.2–q13 | Angelman syndrome | array CGH | copy number variation | deletion | breakpoints | birth incidence | Breakpoints | Birth incidence | Copy number variation | Array CGH | 15q11.2-q13 | Deletion | MOLECULAR CHARACTERIZATION | 15Q11-Q13 REARRANGEMENTS | PREVALENCE | IDENTIFICATION | FEATURES | CHILDREN | ARRAY-CGH | GENETICS & HEREDITY | EPILEPSY | PRADER-WILLI-SYNDROME | Chromosome Deletion | Chromosome Duplication | Angelman Syndrome - epidemiology | Humans | Angelman Syndrome - diagnosis | Child, Preschool | Male | Incidence | Chromosomes, Human, Pair 15 | Adolescent | Angelman Syndrome - genetics | Denmark - epidemiology | Female | Child | Medicine, Experimental | Medical research | Analysis | Mandible | Epilepsy | Uniparental disomy | Clonal deletion | Ataxia | Children | Mutation | Diagnosis | Health risk assessment | Chromosome 15 | Age | Ubiquitin-protein ligase | Genotypes
Journal Article
Movement Disorders, ISSN 0885-3185, 01/2017, Volume 32, Issue 1, pp. 94 - 105
ABSTRACT Constipation is among the first nonmotor symptoms to develop in the prodromal phase of PD. Pathological alpha‐synuclein deposition is present...
constipation | gastrointestinal | nonmotor symptom | transit time | Parkinson | AUTONOMIC SYMPTOMS | PELVIC FLOOR DYSSYNERGIA | COLONIC TRANSIT-TIME | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | MULTIPLE SYSTEM ATROPHY | GASTROINTESTINAL SYMPTOMS | ANORECTAL FUNCTION | EXTERNAL ANAL-SPHINCTER | NONMOTOR SYMPTOMS | QUALITY-OF-LIFE | Parkinson Disease - complications | Constipation - diagnosis | Constipation - physiopathology | Constipation - etiology | Humans | Disease Progression | Development and progression | Constipation | Prevalence studies (Epidemiology) | Parkinson's disease | Gastrointestinal tract diseases | Neurodegenerative diseases | Sleep (REM) | Population studies | Gastrointestinal tract | Colon | Synuclein | Movement disorders
constipation | gastrointestinal | nonmotor symptom | transit time | Parkinson | AUTONOMIC SYMPTOMS | PELVIC FLOOR DYSSYNERGIA | COLONIC TRANSIT-TIME | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | MULTIPLE SYSTEM ATROPHY | GASTROINTESTINAL SYMPTOMS | ANORECTAL FUNCTION | EXTERNAL ANAL-SPHINCTER | NONMOTOR SYMPTOMS | QUALITY-OF-LIFE | Parkinson Disease - complications | Constipation - diagnosis | Constipation - physiopathology | Constipation - etiology | Humans | Disease Progression | Development and progression | Constipation | Prevalence studies (Epidemiology) | Parkinson's disease | Gastrointestinal tract diseases | Neurodegenerative diseases | Sleep (REM) | Population studies | Gastrointestinal tract | Colon | Synuclein | Movement disorders
Journal Article
2013, 2nd edition., ISBN 0393733688, 240
Book
Movement Disorders, ISSN 0885-3185, 04/2017, Volume 32, Issue 4, pp. 631 - 631
Journal Article
Journal of Advanced Nursing, ISSN 0309-2402, 02/2011, Volume 67, Issue 2, pp. 408 - 417
P>Aim. This paper is a report of an exploration of patients' lifeworld and way of managing life with advanced Parkinson's disease prior to Deep Brain...
Long-term illness | Nursing | Parkinson's disease | Deep Brain Stimulation | Hermeneutic phenomenology | Lived experience | Interviews | BILATERAL STIMULATION | lived experience | CARE DECISION-MAKING | nursing | SYMPTOMS | hermeneutic phenomenology | interviews | STRATEGIES | SUBTHALAMIC NUCLEUS | 5-YEAR FOLLOW-UP | CHRONIC ILLNESS | long-term illness | IMPROVEMENT | DEEP-BRAIN-STIMULATION | QUALITY-OF-LIFE | Nursing Methodology Research | Parkinson Disease - therapy | Activities of Daily Living - psychology | Drug Administration Schedule | Attitude to Health | Levodopa - therapeutic use | Humans | Middle Aged | Male | Dyskinesias - etiology | Parkinson Disease - psychology | Disease Progression | Adult | Female | Aged | Qualitative Research | Chronic Disease | Adaptation, Psychological | Dopa | Nurses | Public health | Phenomenology | Brain | Uncertainty | Parkinsons disease | Data collection | Patients
Long-term illness | Nursing | Parkinson's disease | Deep Brain Stimulation | Hermeneutic phenomenology | Lived experience | Interviews | BILATERAL STIMULATION | lived experience | CARE DECISION-MAKING | nursing | SYMPTOMS | hermeneutic phenomenology | interviews | STRATEGIES | SUBTHALAMIC NUCLEUS | 5-YEAR FOLLOW-UP | CHRONIC ILLNESS | long-term illness | IMPROVEMENT | DEEP-BRAIN-STIMULATION | QUALITY-OF-LIFE | Nursing Methodology Research | Parkinson Disease - therapy | Activities of Daily Living - psychology | Drug Administration Schedule | Attitude to Health | Levodopa - therapeutic use | Humans | Middle Aged | Male | Dyskinesias - etiology | Parkinson Disease - psychology | Disease Progression | Adult | Female | Aged | Qualitative Research | Chronic Disease | Adaptation, Psychological | Dopa | Nurses | Public health | Phenomenology | Brain | Uncertainty | Parkinsons disease | Data collection | Patients
Journal Article
Journal of Neurology, ISSN 0340-5354, 11/2013, Volume 260, Issue 11, pp. 2701 - 2714
Motor complications in Parkinson's disease (PD) result from the short half-life and irregular plasma fluctuations of oral levodopa. When strategies of...
Duodenal levodopa infusion | Parkinson's disease | Deep brain stimulation | Apomorphine | SUBTHALAMIC NUCLEUS STIMULATION | BILATERAL STIMULATION | SUBCUTANEOUS APOMORPHINE | FOLLOW-UP | CONTINUOUS APOMORPHINE INFUSION | CLINICAL NEUROLOGY | UNILATERAL PALLIDOTOMY | NEUROPSYCHIATRIC DISORDERS | QUALITY-OF-LIFE | MOTOR COMPLICATIONS | Parkinson Disease - therapy | Drug Administration Routes | Evidence-Based Practice | Levodopa - administration & dosage | Apomorphine - administration & dosage | Humans | Deep Brain Stimulation | Antiparkinson Agents - administration & dosage | Carbidopa - administration & dosage | Complications and side effects | Analysis | Dosage and administration | Diagnosis | Drug therapy | Brain stimulation | Age | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Duodenal levodopa infusion | Parkinson's disease | Deep brain stimulation | Apomorphine | SUBTHALAMIC NUCLEUS STIMULATION | BILATERAL STIMULATION | SUBCUTANEOUS APOMORPHINE | FOLLOW-UP | CONTINUOUS APOMORPHINE INFUSION | CLINICAL NEUROLOGY | UNILATERAL PALLIDOTOMY | NEUROPSYCHIATRIC DISORDERS | QUALITY-OF-LIFE | MOTOR COMPLICATIONS | Parkinson Disease - therapy | Drug Administration Routes | Evidence-Based Practice | Levodopa - administration & dosage | Apomorphine - administration & dosage | Humans | Deep Brain Stimulation | Antiparkinson Agents - administration & dosage | Carbidopa - administration & dosage | Complications and side effects | Analysis | Dosage and administration | Diagnosis | Drug therapy | Brain stimulation | Age | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2016, Volume 32, Issue S1, pp. 1 - 409
Journal Article
Journal of Extracellular Vesicles, ISSN 2001-3078, 12/2018, Volume 7, Issue 1, pp. 1535750 - 43
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular...
extracellular vesicles | rigor | exosomes | reproducibility | guidelines | standardization | microparticles | microvesicles | minimal information requirements | ectosomes | HUMAN URINARY EXOSOMES | FETAL BOVINE | PREANALYTICAL PARAMETERS | CELL-DERIVED MICROPARTICLES | CELL BIOLOGY | FIELD-FLOW FRACTIONATION | MEMBRANE-VESICLES | PROSTATE-CANCER | SURFACE-PLASMON RESONANCE | SIZE-EXCLUSION CHROMATOGRAPHY | CIRCULATING MICROPARTICLES | Vesicles | Physiology | Biosynthesis | Scientists | Metastasis | Exosomes | Microparticles | Polls & surveys | Cancer | Apoptosis | Membranes cel·lulars | Cell interaction | Cell membranes | Interacció cel·lular | Cellbiologi | Cell Biology
extracellular vesicles | rigor | exosomes | reproducibility | guidelines | standardization | microparticles | microvesicles | minimal information requirements | ectosomes | HUMAN URINARY EXOSOMES | FETAL BOVINE | PREANALYTICAL PARAMETERS | CELL-DERIVED MICROPARTICLES | CELL BIOLOGY | FIELD-FLOW FRACTIONATION | MEMBRANE-VESICLES | PROSTATE-CANCER | SURFACE-PLASMON RESONANCE | SIZE-EXCLUSION CHROMATOGRAPHY | CIRCULATING MICROPARTICLES | Vesicles | Physiology | Biosynthesis | Scientists | Metastasis | Exosomes | Microparticles | Polls & surveys | Cancer | Apoptosis | Membranes cel·lulars | Cell interaction | Cell membranes | Interacció cel·lular | Cellbiologi | Cell Biology
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 2014, Volume 16, Issue 1, pp. 434 - 434
Introduction: A key phenomenon in rheumatoid arthritis is the formation of lymphoid follicles in the inflamed synovial membrane. C-X-C motif chemokine 13...
MIGRATION | CELLS | ANTIBODY | GERMINAL CENTER | RHEUMATOLOGY | TNF | SYNOVITIS | Severity of Illness Index | Predictive Value of Tests | Antibodies, Monoclonal, Humanized - therapeutic use | Prognosis | Arthritis, Rheumatoid - blood | Joints - drug effects | Humans | Middle Aged | Joints - pathology | Male | Treatment Outcome | Methotrexate - therapeutic use | Chemokine CXCL13 - blood | Remission Induction | Time Factors | Arthritis, Rheumatoid - drug therapy | Female | Adalimumab | Drug Therapy, Combination | Arthritis, Rheumatoid - diagnosis | Early Diagnosis | Joints - metabolism | Antirheumatic Agents - therapeutic use
MIGRATION | CELLS | ANTIBODY | GERMINAL CENTER | RHEUMATOLOGY | TNF | SYNOVITIS | Severity of Illness Index | Predictive Value of Tests | Antibodies, Monoclonal, Humanized - therapeutic use | Prognosis | Arthritis, Rheumatoid - blood | Joints - drug effects | Humans | Middle Aged | Joints - pathology | Male | Treatment Outcome | Methotrexate - therapeutic use | Chemokine CXCL13 - blood | Remission Induction | Time Factors | Arthritis, Rheumatoid - drug therapy | Female | Adalimumab | Drug Therapy, Combination | Arthritis, Rheumatoid - diagnosis | Early Diagnosis | Joints - metabolism | Antirheumatic Agents - therapeutic use
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 264 - 274
Summary Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative movement disorder that is characterised by autonomic...
Neurology | DIAGNOSIS | GROUP EMSA-SG | NUCLEUS | DISORDERS | SYMPTOMS | PATIENT | QUALITY-OF-LIFE | DEEP BRAIN-STIMULATION | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Severity of Illness Index | Prospective Studies | Europe | Humans | Middle Aged | Male | Parkinson Disease - physiopathology | Autonomic Nervous System Diseases - diagnosis | Disease Progression | Autonomic Nervous System Diseases - mortality | Cerebellar Ataxia - physiopathology | Phenotype | Autonomic Nervous System Diseases - physiopathology | Parkinson Disease - diagnosis | Multiple System Atrophy - mortality | Aged | Multiple System Atrophy - classification | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Cerebellar Ataxia - mortality | Cohort Studies | Parkinson Disease - mortality | Atrophy | Medical colleges | Nervous system diseases | Neurosciences | Analysis | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Neurology | DIAGNOSIS | GROUP EMSA-SG | NUCLEUS | DISORDERS | SYMPTOMS | PATIENT | QUALITY-OF-LIFE | DEEP BRAIN-STIMULATION | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Severity of Illness Index | Prospective Studies | Europe | Humans | Middle Aged | Male | Parkinson Disease - physiopathology | Autonomic Nervous System Diseases - diagnosis | Disease Progression | Autonomic Nervous System Diseases - mortality | Cerebellar Ataxia - physiopathology | Phenotype | Autonomic Nervous System Diseases - physiopathology | Parkinson Disease - diagnosis | Multiple System Atrophy - mortality | Aged | Multiple System Atrophy - classification | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Cerebellar Ataxia - mortality | Cohort Studies | Parkinson Disease - mortality | Atrophy | Medical colleges | Nervous system diseases | Neurosciences | Analysis | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
International Journal of Nursing Studies, ISSN 0020-7489, 2010, Volume 47, Issue 10, pp. 1228 - 1236
Deep Brain Stimulation for Parkinson's disease is a promising treatment for patients who can no longer be treated satisfactorily with -dopa. Deep Brain...
Chronic illness | Lived experience | Parkinson's disease | Deep Brain Stimulation | Longitudinal study | Interview | BILATERAL STIMULATION | NURSING | SELF | THERAPY | NUCLEUS | SUBTHALAMIC STIMULATION | QUALITY-OF-LIFE | Parkinson Disease - therapy | Parkinson Disease - physiopathology | Parkinson Disease - psychology | Longitudinal Studies | Humans | Chronic diseases | Medicine, Experimental | Brain | Medical research | Public health | Studies | Neurosurgery | Medical treatment | Parkinsons disease | Quality of life
Chronic illness | Lived experience | Parkinson's disease | Deep Brain Stimulation | Longitudinal study | Interview | BILATERAL STIMULATION | NURSING | SELF | THERAPY | NUCLEUS | SUBTHALAMIC STIMULATION | QUALITY-OF-LIFE | Parkinson Disease - therapy | Parkinson Disease - physiopathology | Parkinson Disease - psychology | Longitudinal Studies | Humans | Chronic diseases | Medicine, Experimental | Brain | Medical research | Public health | Studies | Neurosurgery | Medical treatment | Parkinsons disease | Quality of life
Journal Article
Ugeskrift for laeger, 01/2015, Volume 177, Issue 4, p. V66691
Journal Article
Ugeskrift for laeger, 01/2015, Volume 177, Issue 4, p. V66691
Journal Article
PLoS ONE, ISSN 1932-6203, 2014, Volume 9, Issue 12, p. e115815
Swine influenza causes concern for global veterinary and public health officials. In continuing two previous networks that initiated the surveillance of swine...
CVI Virologie | CVI Virology | Virologie | Virology | A VIRUS | TRANSMISSION | EVOLUTION | PORCINE | UNIVERSAL PRIMER SET | RT-PCR | MULTIDISCIPLINARY SCIENCES | PANDEMIC H1N1 2009 | GENETIC REASSORTMENT | PCR ASSAY | H3N2 | Influenza A virus - physiology | Orthomyxoviridae Infections - veterinary | Swine Diseases - virology | Europe | Epidemiological Monitoring - veterinary | Influenza A virus - isolation & purification | Swine Diseases - epidemiology | Orthomyxoviridae Infections - diagnosis | Orthomyxoviridae Infections - epidemiology | Antigens, Viral - immunology | Swine Diseases - diagnosis | Animals | Influenza A virus - immunology | Influenza A virus - classification | Orthomyxoviridae Infections - virology | Swine - virology | Swine influenza | Pandemics | Laboratories | Viruses | Veterinary medicine | Epidemiology | Incidence | Hogs | Surveillance | Swine | Influenza | Diagnostic software | Influenza A | Livestock | Diagnostic systems | Software | Public health
CVI Virologie | CVI Virology | Virologie | Virology | A VIRUS | TRANSMISSION | EVOLUTION | PORCINE | UNIVERSAL PRIMER SET | RT-PCR | MULTIDISCIPLINARY SCIENCES | PANDEMIC H1N1 2009 | GENETIC REASSORTMENT | PCR ASSAY | H3N2 | Influenza A virus - physiology | Orthomyxoviridae Infections - veterinary | Swine Diseases - virology | Europe | Epidemiological Monitoring - veterinary | Influenza A virus - isolation & purification | Swine Diseases - epidemiology | Orthomyxoviridae Infections - diagnosis | Orthomyxoviridae Infections - epidemiology | Antigens, Viral - immunology | Swine Diseases - diagnosis | Animals | Influenza A virus - immunology | Influenza A virus - classification | Orthomyxoviridae Infections - virology | Swine - virology | Swine influenza | Pandemics | Laboratories | Viruses | Veterinary medicine | Epidemiology | Incidence | Hogs | Surveillance | Swine | Influenza | Diagnostic software | Influenza A | Livestock | Diagnostic systems | Software | Public health
Journal Article